Possibility of combined therapy with an oral phosphodiesterase-4 inhibitor (apremilast) and dihydrofolatereductase inhibitor (methotrexate) in patients with psoriatic arthritis plaque psoriasis - PDF (Russian)


Copyright (c) 2019 Russian academy of sciences



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies